Ask Warren

Genomictree

228760 · KOSDAQ · ₩228760 · 지노믹트리

₩9,970▲ ₩70 (0.71%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩842M₩382M₩826M₩897M₩1.7B₩316M₩824M₩693M
Cost of sales₩803M₩610M₩885M₩797M₩680M₩684M₩841M₩832M
Gross profit₩39M−₩228M−₩59M₩100M₩1B−₩367M−₩16M−₩139M
Operating income−₩2.6B−₩3B−₩2.6B−₩3.4B−₩1.5B−₩3.7B−₩3.7B−₩3.9B
Net income−₩2.5B−₩2B−₩2B−₩2.8B−₩1.5B−₩3B−₩1.8B−₩3.1B
Net income to shareholders−₩2.4B−₩1.9B−₩1.9B−₩2.7B−₩1.4B−₩2.9B−₩1.7B−₩3.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩124B₩126B₩121B₩123B₩124B₩128B₩131B₩132B
Current assets₩81B₩77B₩79B₩87B₩88B₩95B₩98B₩98B
Cash and equivalents₩17B₩8.7B₩16B₩16B₩17B₩27B₩26B₩22B
Total liabilities₩2.5B₩2.5B₩5.5B₩6.9B₩6.3B₩6.4B₩6.4B₩8.1B
Current liabilities₩1.3B₩1.4B₩4.4B₩5.1B₩4.6B₩4.7B₩4.8B₩5.1B
Borrowings₩0₩0₩2.3B₩2.2B₩2.1B₩2B₩2B₩1.9B
Total equity₩122B₩123B₩115B₩116B₩117B₩122B₩124B₩124B
Shareholders' equity₩122B₩123B₩115B₩116B₩117B₩121B₩124B₩124B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.5B−₩3.4B−₩3.2B−₩2.4B−₩1.6B−₩3B−₩4.7B−₩2.4B
Capital spending₩1.6B₩76M₩46M₩102M₩2.6B₩0₩35M₩12M
Free cash flow−₩3.1B−₩3.5B−₩3.3B−₩2.5B−₩4.1B−₩3B−₩4.7B−₩2.4B

Consolidated where available. Amounts in won.

Also known as: Genomictree / 지노믹트리 / 228760 / KRX:228760

Source: KRX statistical information